https://www.hcplive.com/view/study-estimates-lifetime-benefit-of-sglt2-glp-1-ra-nonsteroidal-mra-use-in-type-2-diabetes
0
0
11/12/23 at 3:29pm
Organization
Hcplive.com
Author
Patrick Campbell
Brendon Neuen, MBBS, PhD, discusses the results of a study he presented at AHA 2023 estimating the lifetime benefit of combination therapy in patients with type 2 diabetes and albuminuria.
Create an account
or login to join the discussion